Approval · Notice of Compliance 21711 · 2019
JINARC: Notice of Compliance 21711
Issued January 9, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21711
- Date
- January 9, 2019
- Company
- Otsuka Pharmaceutical Co LtdChiyoda-Ku Tokyo, --, Japan
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To add further detailed description of the currently approvved indication and clinical use
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JINARC | Not yet assigned | — |